| Name | Market | Market CAP | Share price | Daily share movement |
|---|---|---|---|---|
| 1414 Degrees Ltd | ASX | $16.11 m | 0.02 AUD | -4.35% |
| 1933 Industries Inc. | CSE | $5.21 m | 0.01 CAD | 100.00% |
| 1stdibs.com Inc. | NASDAQ | $199.54 m | 5.86 USD | 1.56% |
| 22nd Century Group Inc | NASDAQ | $203.82 k | 0.37 USD | -15.33% |
| 3D Oil Ltd | ASX | $41.94 m | 0.08 AUD | 0.00% |
| 3D Systems | NYSE | $250.18 m | 1.38 USD | 0.00% |
| 4D Molecular Therapeutics Inc. | NASDAQ | $589.73 m | 10.46 USD | -3.06% |
| 80 Mile PLC | AIM | £42.68 m | 0.79 GBX | 0.38% |
| 8x8 Inc | NASDAQ | $315.14 m | 2.16 USD | 0.00% |
| a.k.a. Brands Holding Corp. | NYSE | $86.05 m | 7.78 USD | 2.10% |
| A10 Networks Inc | NYSE | $2.33 b | 32.36 USD | 10.52% |
| AAR | NYSE | $4.24 b | 105.50 USD | 1.51% |
| Aardvark Therapeutics Inc. | NASDAQ | $19.92 m | 0.91 USD | -20.87% |
| Abcourt Mines Inc. | TSX-V | $62.89 m | 0.05 CAD | 11.11% |
| Abercrombie & Fitch | NYSE | $6.24 b | 147.01 USD | 2.89% |
| Aberdeen International | TSX | $2.41 m | 0.02 CAD | 0.00% |
| abrdn Life Sciences Investors | NYSE | $547.6 m | 17.49 USD | -0.74% |
| ABx Group Ltd | ASX | $7.54 m | 0.01 AUD | 0.00% |
| AC Immune SA | NASDAQ | $208.8 m | 2.10 USD | -0.47% |
| Acacia Research | NASDAQ | $399.16 m | 4.09 USD | 0.74% |
| Accel Entertainment Inc. | NYSE | $1.08 b | 13.46 USD | 0.07% |
| Accelerate Resources Ltd | ASX | $5.18 m | 0.00 AUD | 0.00% |
| Acceleware Ltd | TSX-V | $17.18 m | 0.12 CAD | 0.00% |
| Accendra Health Inc. | NYSE | $6.6 m | 0.09 USD | -35.08% |
| Acco Brands Corporation | NYSE | $517.11 m | 5.60 USD | 4.48% |
| Aclaris Therapeutics Inc. | NASDAQ | $555.14 m | 3.50 USD | 3.55% |
| Acme United Corporation. | NYSE-A | $265.8 m | 66.99 USD | 0.04% |
| ACNB Corporation | NASDAQ | $674.91 m | 66.40 USD | 0.51% |
| Acorn Energy Inc. | NASDAQ | $34.32 m | 13.54 USD | 0.67% |
| Acrivon Therapeutics Inc. | NASDAQ | $66.94 m | 1.56 USD | 9.09% |
| Acrux | ASX | $6.12 m | 0.01 AUD | 5.26% |
| Actinogen Medical Ltd | ASX | $30.96 m | 0.01 AUD | -82.22% |
| Acuity RM Group | AIM | £5.33 m | 1.58 GBX | 1.94% |
| Acumen Pharmaceuticals Inc. | NASDAQ | $14.06 m | 0.19 USD | -15.52% |
| AdAlta Ltd | ASX | $6.42 m | 0.00 AUD | -33.33% |
| Adamas Trust Inc. | NASDAQ | $435.27 m | 4.82 USD | -2.03% |
| AdaptHealth Corp. | NASDAQ | $1.01 b | 7.37 USD | -2.12% |
| Adavale Resources Ltd | ASX | $13.64 m | 0.03 AUD | 3.70% |
| ADC Therapeutics SA | NYSE | $192.71 m | 1.37 USD | 1.48% |
| ADF Group | TSX | $490.83 m | 17.19 CAD | 2.38% |